We can’t show the full text here under this license. Use the link below to read it at the source.
Longitudinal evaluation of neurologic‐post acute sequelae SARS‐CoV‐2 infection symptoms
Long-term changes in brain-related symptoms after COVID-19 infection
AI simplified
Abstract
Fifty-six participants with neurologic symptoms following SARS-CoV-2 infection were assessed, with 33.3% reporting complete symptom resolution by 6 months.
- The most common neurologic symptoms reported at baseline were fatigue (89.3%) and headaches (80.4%).
- Memory impairment (68.8%) and decreased concentration (61.5%) were the most prevalent symptoms at the 6-month follow-up.
- Average scores on the Montreal cognitive assessment improved overall, though 26.3% of participants experienced a decrease in scores.
- A syndrome characterized by tremor, ataxia, and cognitive dysfunction was observed in 7.1% of participants.
- Participants generally reported a reduction in the severity of all symptoms from baseline to 6 months.
AI simplified
Key numbers
33.3%
Symptom Resolution Rate
Participants reporting complete resolution of symptoms at 6 months
56
Participant Cohort Size
Total participants enrolled in the study with neurologic symptoms post-COVID-19
89.3%
Fatigue Prevalence
Participants reporting fatigue as a symptom following acute COVID-19 infection